Ludovic Leriche

690 total citations
10 papers, 588 citations indexed

About

Ludovic Leriche is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Ludovic Leriche has authored 10 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in Ludovic Leriche's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Ludovic Leriche is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Ludovic Leriche collaborates with scholars based in France, United States and Italy. Ludovic Leriche's co-authors include Pierre Sokoloff, Christian E. Gross, Erwan Bézard, Thomas Boraud, Sandrine Ferry, U Mach, Holger Stark, Jorge Díaz, Jean‐Charles Schwartz and Jacques Louvel and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and Psychopharmacology.

In The Last Decade

Ludovic Leriche

10 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludovic Leriche France 9 452 231 225 84 54 10 588
H. Ryoo United States 9 583 1.3× 284 1.2× 277 1.2× 145 1.7× 69 1.3× 9 758
Fatiha Radja Canada 12 559 1.2× 108 0.5× 326 1.4× 78 0.9× 48 0.9× 14 672
Christian E. Gross France 7 549 1.2× 435 1.9× 159 0.7× 108 1.3× 51 0.9× 9 717
Jarod Swant United States 11 541 1.2× 85 0.4× 236 1.0× 208 2.5× 24 0.4× 13 691
Mark D. Kelland United States 14 470 1.0× 159 0.7× 204 0.9× 105 1.3× 29 0.5× 20 546
Marie‐Louise Kemel France 9 368 0.8× 62 0.3× 252 1.1× 103 1.2× 31 0.6× 13 473
Shao‐Pii Onn United States 11 448 1.0× 165 0.7× 190 0.8× 200 2.4× 21 0.4× 14 578
Lucas Salomon France 9 392 0.9× 65 0.3× 242 1.1× 77 0.9× 23 0.4× 16 559
Liudmila Mus Russia 9 384 0.8× 50 0.2× 354 1.6× 71 0.8× 37 0.7× 12 561
Maria Meringolo Italy 13 238 0.5× 137 0.6× 143 0.6× 111 1.3× 26 0.5× 24 461

Countries citing papers authored by Ludovic Leriche

Since Specialization
Citations

This map shows the geographic impact of Ludovic Leriche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Leriche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Leriche more than expected).

Fields of papers citing papers by Ludovic Leriche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Leriche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Leriche. The network helps show where Ludovic Leriche may publish in the future.

Co-authorship network of co-authors of Ludovic Leriche

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Leriche. A scholar is included among the top collaborators of Ludovic Leriche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Leriche. Ludovic Leriche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cosi, Cristina, Jean‐Claude Martel, Agnès L. Auclair, et al.. (2020). Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist. European Journal of Pharmacology. 890. 173635–173635. 20 indexed citations
2.
Slifstein, Mark, Anissa Abi‐Dargham, Ragy R. Girgis, et al.. (2019). Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO. Psychopharmacology. 237(2). 519–527. 14 indexed citations
3.
Sokoloff, Pierre, Ludovic Leriche, Jorge Díaz, Jacques Louvel, & R. Pumain. (2012). Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(2). 107–124. 40 indexed citations
4.
Leriche, Ludovic, Tomas Björklund, Nathalie Breysse, et al.. (2009). Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy. Journal of Neuroscience. 29(5). 1544–1553. 28 indexed citations
5.
Leriche, Ludovic, Jorge Díaz, & Pierre Sokoloff. (2004). Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor. Neurotoxicity Research. 6(1). 63–71. 18 indexed citations
6.
Sokoloff, Pierre, Ludovic Leriche, & Jorge Díaz. (2004). S10 BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) BRIDGES THE GAP BETWEEN DOPAMINE AND GLUTAMATE DYSFUNCTIONS IN SCHIZOPHRENIA. Behavioural Pharmacology. 15(5). A4–A4. 2 indexed citations
7.
Smirnova, Maria, et al.. (2004). Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference. Psychopharmacology. 175(2). 127–33. 20 indexed citations
8.
Leriche, Ludovic, Jean‐Charles Schwartz, & Pierre Sokoloff. (2003). The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology. 45(2). 174–181. 66 indexed citations
9.
Bézard, Erwan, Sandrine Ferry, U Mach, et al.. (2003). Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nature Medicine. 9(6). 762–767. 328 indexed citations
10.
Guillin, Olivier, Nathalie Griffon, Erwan Bézard, et al.. (2003). Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. European Journal of Pharmacology. 480(1-3). 89–95. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Ryoo Breakdown of academic impact, for papers by Fatiha Radja Breakdown of academic impact, for papers by Christian E. Gross Breakdown of academic impact, for papers by Jarod Swant Breakdown of academic impact, for papers by Mark D. Kelland Breakdown of academic impact, for papers by Marie‐Louise Kemel Breakdown of academic impact, for papers by Shao‐Pii Onn Breakdown of academic impact, for papers by Lucas Salomon Breakdown of academic impact, for papers by Liudmila Mus Breakdown of academic impact, for papers by Maria Meringolo
Rankless by CCL
2026